Blood cannabinoid profiles differed between symptomatic and asymptomatic periods in suspected CHS patients
Emergency department patients with suspected cannabinoid hyperemesis syndrome showed detailed cannabis use patterns and different whole-blood cannabinoid profiles during symptomatic versus asymptomatic episodes.
Quick Facts
What This Study Found
Whole-blood cannabinoid profiles differed between symptomatic and asymptomatic periods in patients with suspected CHS, providing biological data to complement clinical diagnosis. Detailed cannabis use patterns (frequency, mode, product type) were characterized.
Key Numbers
ED patients with symptomatic cyclic vomiting after chronic cannabis use enrolled. Whole-blood cannabinoid profiles measured during both symptomatic and asymptomatic periods. Cannabis use patterns including frequency, mode, and product type characterized.
How They Did This
Prospective observational cohort study recruiting ED patients during symptomatic CHS episodes. Characterized detailed cannabis use patterns and measured whole-blood cannabinoid profiles during symptomatic and asymptomatic periods.
Why This Research Matters
CHS diagnosis relies on clinical criteria, and blood cannabinoid data could improve diagnostic accuracy. Understanding which use patterns and cannabinoid profiles are associated with symptoms helps identify at-risk users.
The Bigger Picture
CHS is increasingly recognized in emergency departments as cannabis potency and use frequency rise. Objective blood markers could help distinguish CHS from other causes of cyclic vomiting and improve care.
What This Study Doesn't Tell Us
Small prospective cohort from ED recruitment. Suspected CHS diagnosis (not always confirmed). Blood draws during symptomatic episodes may be affected by recent cannabis cessation or reduced intake. Cannabinoid profiles are complex and not standardized for CHS diagnosis.
Questions This Raises
- ?Could blood cannabinoid profiles be developed into a diagnostic test for CHS?
- ?Do specific cannabinoid metabolite ratios predict who will develop CHS among heavy users?
Trust & Context
- Key Stat:
- Blood cannabinoid profiles differed between CHS symptomatic and asymptomatic periods
- Evidence Grade:
- Small prospective cohort with objective biological measurement. Preliminary data requiring validation in larger samples.
- Study Age:
- Published 2023.
- Original Title:
- Cannabis Use Patterns and Whole-Blood Cannabinoid Profiles of Emergency Department Patients With Suspected Cannabinoid Hyperemesis Syndrome.
- Published In:
- Annals of emergency medicine, 82(2), 121-130 (2023)
- Authors:
- Wightman, Rachel S(5), Metrik, Jane(16), Lin, Timmy R(3), Li, Yu, Badea, Adina, Almeida, Robert, Collins, Alexandra B, Beaudoin, Francesca L
- Database ID:
- RTHC-05025
Evidence Hierarchy
Enrolls participants and follows them forward in time.
What do these levels mean? →Frequently Asked Questions
What is cannabinoid hyperemesis syndrome?
CHS is a condition in heavy, chronic cannabis users characterized by episodes of severe nausea and vomiting that typically resolve with cannabis cessation. Hot baths or showers often provide temporary relief. It is diagnosed clinically, though this study explores whether blood cannabinoid measurements could aid diagnosis.
Why do some heavy users get CHS and others don't?
This is not yet understood. This study found differences in blood cannabinoid profiles during symptomatic vs. asymptomatic periods, suggesting biological factors may explain individual susceptibility. Use patterns (frequency, product type, mode of consumption) may also play a role.
Read More on RethinkTHC
- 420-sober-survival-guide
- CBT-cannabis-recovery
- THC-potency-increase-over-time
- cannabis-harm-reduction-opioids-alcohol-replacement
- cannabis-legalization-effects-health-data
- cannabis-relapse-cycle-pattern
- cannabis-tolerance-break-guide
- cold-turkey-vs-taper-quit-weed
- dating-sober-after-quitting-weed
- exercise-quitting-weed-anxiety-brain
- grieving-quitting-weed-loss
- help-someone-quit-weed
- how-to-cut-back-on-weed-moderation
- how-to-quit-weed
- journaling-weed-withdrawal
- marijuana-anonymous-SMART-recovery-compare
- meditation-mindfulness-weed-withdrawal
- microdosing-cannabis-benefits
- partner-still-smokes-weed
- partner-still-smokes-weed-quitting
- pink-cloud-sobriety-cannabis
- quit-weed-cold-turkey
- quit-weed-or-cut-back-which-is-better
- quit-weed-regret-went-back
- quitting-weed-20s
- quitting-weed-30s
- quitting-weed-after-years
- quitting-weed-during-crisis-divorce-job-loss
- quitting-weed-exercise
- quitting-weed-grief-loss-coping
- quitting-weed-legal-state
- quitting-weed-success-stories
- quitting-weed-triggers-environment
- relapsed-smoking-weed-what-to-do
- relapsed-weed
- safer-cannabis-use-guidelines
- should-i-quit-weed
- sober-music-festival-concert-without-weed
- sober-october-weed
- supplements-weed-withdrawal
- telling-friends-quitting-weed
- tolerance-break-weed
- weed-for-opioid-withdrawal
- weed-relapse-prevention-plan
- weed-relapse-why-it-happens
- weed-ritual-replacement
- weed-ruined-relationships
- weed-social-media-triggers-quit
Cite This Study
https://rethinkthc.com/research/RTHC-05025APA
Wightman, Rachel S; Metrik, Jane; Lin, Timmy R; Li, Yu; Badea, Adina; Almeida, Robert; Collins, Alexandra B; Beaudoin, Francesca L. (2023). Cannabis Use Patterns and Whole-Blood Cannabinoid Profiles of Emergency Department Patients With Suspected Cannabinoid Hyperemesis Syndrome.. Annals of emergency medicine, 82(2), 121-130. https://doi.org/10.1016/j.annemergmed.2023.03.005
MLA
Wightman, Rachel S, et al. "Cannabis Use Patterns and Whole-Blood Cannabinoid Profiles of Emergency Department Patients With Suspected Cannabinoid Hyperemesis Syndrome.." Annals of emergency medicine, 2023. https://doi.org/10.1016/j.annemergmed.2023.03.005
RethinkTHC
RethinkTHC Research Database. "Cannabis Use Patterns and Whole-Blood Cannabinoid Profiles o..." RTHC-05025. Retrieved from https://rethinkthc.com/research/wightman-2023-cannabis-use-patterns-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.